Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 30 Oct 2026 for TAKEDA PHARMACEUTICAL CO LTD, €839k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Teresa Bitetti: trading record in brief

Teresa Bitetti discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). Between 13 July 2026 and 30 October 2026, the trades on record add up to 2 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 30 October 2026 with a transaction (€839k) in Takeda Pharmaceutical Co Ltd. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Teresa Bitetti

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    President, Global Oncology Business UnitExecutives(filed)Takeda Pharmaceutical Co Ltd
    940,104 USD0Source
    46,609 shares@ US$20.17American Depositary Shares (ADSs)SEC144:0001493152-26-049485
  • ●
    President, Global Oncology Business UnitExecutivesTakeda Pharmaceutical Co Ltd
    908,019 USD33Source
    54,210 shares@ US$16.750.0015% mcap100.0% of flowAmerican Depositary Shares (ADSs)SEC144:0001395064-26-000302

2 of 2 declarations